Daxor Corporation

Rentabilidade por seis meses: +17.29%
Rendimento de dividendos: 0%
Setor: Healthcare

8.75 $

0 $ 0%
7.05 $
9.89 $

paper.min_max_per_year

Cronograma de promoção Daxor Corporation

Parâmetros básicos

IPO date
1992-03-17
ISIN
US2394671034
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
1.31
Дивиденд ао
0.06
Сайт

Nota

Subestimação
Nome Significado Nota
P/S 17.34 1
P/BV 1.03 9
P/E 68.89 1
Eficiência
Nome Significado Nota
ROA 1.5 1
ROE 1.54 1
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0.6429 6.43
Crescimento médio dos dividendos -29.17 0
Obrigação
Nome Significado Nota
Debt/EBITDA 2.29 6
Debt/Ratio 0.0206 10
Debt/Equity 0.0235 10
Impulso de crescimento
Nome Significado Nota
Receita, % -313.95 0
Ebitda, % -166.48 0
EPS, % -125.56 0

paper.price.prices

Preço Common.min. Common.max. Mudar paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 8.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 8.75 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 7.74 $ 0 $ 0 $ +13.05 % 0 % 0 %
common.calendar.number_days.90d 8.05 $ 7.2 $ 9.29 $ +8.74 % 0 % 0 %
common.calendar.number_days.180d 7.46 $ 7.05 $ 9.29 $ +17.29 % 0 % 0 %
common.calendar.number_days.1y 8 $ 7.05 $ 9.89 $ +9.38 % 0 % 0 %
common.calendar.number_days.3y 12.9 $ 7.05 $ 14.23 $ -32.17 % 0 % 0 %
common.calendar.number_days.5y 19.39 $ 7.05 $ 18.3 $ -54.87 % 0 % 0 %
common.calendar.number_days.10y 3.52 $ 3.52 $ 23.78 $ +248.47 % 0 % 0 %
common.calendar.number_days.ytd 8.5 $ 7.05 $ 9.29 $ +2.94 % 0 % 0 %

Principais proprietários

Empresas semelhantes



Gestão da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. Michael Richard Feldschuh Chairman, President & CEO 100k 1969 (56 anos)
Mr. Jonathan Adam Feldschuh Chief Scientific Officer & Director 127.92k 1965 (60 anos)
Mr. Robert J. Michel CPA, CPA, M.B.A. CFO, Chief Compliance Officer & Corporate Secretary N/A 1957 (68 anos)
Ms. Linda Cooper Vice President of Development & Operations N/A
Ms. Kathryn A. Kornafel Senior VP of Marketing & Commercial Development N/A
Mr. Guido Manzo Vice President of Sales N/A
Ms. Jean Oertel Senior Vice President Commercialization & Customer Experience N/A
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H. Chief Medical Officer

Informações da empresa

Endereço: United States, Oak Ridge. TN, 109 Meco Lane - Abrir no google maps, Abrir mapas yandex
Site: https://www.daxor.com

Sobre a empresa Daxor Corporation

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.